Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis Farhat Nasim6 April 2019 3:00 PM ISTTofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing. New...
Prices of 21 New Drugs fixed by NPPA; Details Meghna A Singhania4 April 2019 10:00 AM ISTThe NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder Farhat Nasim2 April 2019 11:50 AM ISTThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
Zydus Wellness to sell shares worth Rs 2575 crore to Cadilla and three others Medical Dialogues Bureau29 Jan 2019 9:20 AM ISTIn a tweet Friday, the Competition Commission of India (CCI) said it "approves the acquisition of shares in Zydus Wellness Limited by True North...
Zydus gets USFDA nod for schizophrenia drug Ruby Khatun Khatun11 Dec 2017 11:00 AM ISTNew Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
Zydus gets USFDA nod for seizure, migraine drug Ruby Khatun Khatun28 Nov 2017 1:53 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
Zydus gets regulatory nod to market Lipaglyn in Mexico Ruby Khatun Khatun11 Nov 2017 10:32 AM ISTNew Delhi: Drug firm Zydus said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for...
Zydus gets USFDA nod for overactive bladder drug Ruby Khatun Khatun6 Oct 2017 9:49 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
Zydus Pharma recalls 44.8 K bottles of antidepressant in US Ruby Khatun Khatun22 Sept 2017 10:57 AM ISTNew Delhi: Cadila Healthcare's US arm, Zydus Pharmaceuticals USA Inc, is recalling 44,800 bottles of antidepressant Paroxetine tablets from the...
